Effects of FER1L4-miR-106a-5p/miR-372-5p-E2F1 regulatory axis on drug resistance in liver cancer chemotherapy

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

Christina Fitzmaurice, Christine A. Allen, Ryan M Barber et al. · JAMA Oncology · 2016 · 6.2K citations · Full text

E2F1 and c-Myc Potentiate Apoptosis through Inhibition of NF-κB Activity that Facilitates MnSOD-Mediated ROS Elimination

Hirokazu Tanaka, Itaru Matsumura, Sachiko Ezoe et al. · Molecular Cell · 2002 · 290 citations · Full text

Inflammation, Redox Signaling, Nf-κb Activity +11

Deregulated expression of miR‐106a predicts survival in human colon cancer patients

Raquel Díaz, Javier Silva, Yolanda Lorenzo et al. · Genes Chromosomes and Cancer · 2008 · 229 citations

Genome-wide Mapping of RELA(p65) Binding Identifies E2F1 as a Transcriptional Activator Recruited by NF-κB upon TLR4 Activation

Ching-Aeng Lim, Fei Yao, Joyce Jing-Yi Wong et al. · Molecular Cell · 2007 · 206 citations · Full text

Transcriptional Regulation, Signaling Pathway, Cell Regulation +8

Long non‐coding <scp>RNA</scp> Fer‐1‐like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR‐106a‐5p in colon cancer

Ben Yue, Bo Sun, Chenchen Liu et al. · Cancer Science · 2015 · 111 citations · Full text

Pathology, Tumor Biology, Cancer Cell Biology +20